Pathways linking neuropsychiatric symptoms with Alzheimer's disease neuroimaging biomarkers and the outcome of incident Mild Cognitive Impairment/ Dementia

  • Geda, Yonas Endale (CoPI)
  • Geda, Yonas Endale (PI)

Project: Research project

Project Details


PUBLIC HEALTH RELEVANCE STATEMENT We and others have shown that both abnormal brain changes and neuropsychiatric symptoms, such as depression and anxiety, are independent risk factors for cognitive decline. Here we propose to fol- low thousands of normal individuals older than 60 years who have undergone both brain imaging and neuropsychiatric assessment in order to determine who develops new-onset cognitive decline. Our results will help the field of Alzheimer's disease to understand the pathways linking abnormal brain changes, neuropsychiatric symptoms and the outcome of mild cognitive impairment or dementia.
Effective start/end date5/1/1811/30/22


  • National Institute on Aging: $355,209.00
  • National Institute on Aging: $431,163.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.